
Quarterly report 2025-Q3
added 10-31-2025
Butterfly Network Market Cap 2011-2026 | BFLY
As of January 21, 2026 Butterfly Network has a market cap of $ 864 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Butterfly Network
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 766 M | 253 M | 388 M | 1.16 B | 120 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.16 B | 120 M | 538 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
AxoGen
AXGN
|
859 M | $ 31.85 | 2.68 % | $ 1.41 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.97 | -1.59 % | $ 644 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.89 | -2.51 % | $ 135 M | ||
|
Alphatec Holdings
ATEC
|
1.55 B | $ 16.95 | -4.48 % | $ 2.42 B | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 312.8 | -0.23 % | $ 8.83 B | ||
|
CONMED Corporation
CNMD
|
1.94 B | $ 41.19 | -0.91 % | $ 1.27 B | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 3.69 | -9.12 % | $ 138 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 50.26 | 3.85 % | $ 7.49 K | ||
|
Boston Scientific Corporation
BSX
|
155 B | $ 91.09 | 3.43 % | $ 134 B | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
235 B | $ 121.01 | -0.61 % | $ 211 B | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
1.43 B | $ 13.79 | -1.11 % | $ 1.09 B | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
175 M | $ 27.84 | 0.04 % | $ 235 M | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
13.9 B | $ 165.75 | -3.35 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
160 M | $ 0.81 | -3.78 % | $ 83.2 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
466 M | $ 13.82 | -5.67 % | $ 374 M | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 18.68 | 0.24 % | $ 122 M | ||
|
IRadimed Corporation
IRMD
|
670 M | $ 102.68 | 0.67 % | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
4.58 B | $ 84.87 | -1.06 % | $ 2.85 B | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
LivaNova PLC
LIVN
|
2.28 B | $ 62.45 | 0.55 % | $ 3.39 B | ||
|
Globus Medical
GMED
|
11.4 B | $ 92.68 | -0.85 % | $ 12.6 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 11.98 | -3.51 % | $ 923 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Pulmonx Corporation
LUNG
|
341 M | $ 1.78 | 0.28 % | $ 69.6 M |